Company Filing History:
Years Active: 1985-2003
Title: The Innovative Contributions of Preston Charles Conrad
Introduction
Preston Charles Conrad is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds aimed at addressing various health conditions. With a total of 3 patents to his name, Conrad's work reflects a commitment to innovation and improving patient outcomes.
Latest Patents
Conrad's latest patents include a crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride. This invention is directed towards a novel crystalline hydrate that has potential uses in inhibiting disease states associated with estrogen deprivation, such as cardiovascular disease, hyperlipidemia, and osteoporosis. Additionally, it addresses other pathological conditions including endometriosis, uterine fibrosis, estrogen-dependent cancers, prostate cancer, benign prostatic hyperplasia, and CNS disorders like Alzheimer's disease. The invention also aims to prevent breast cancer and up-regulate ChAT.
Career Highlights
Conrad is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on innovative research and development, contributing to the advancement of medical science and patient care.
Collaborations
Throughout his career, Conrad has collaborated with several esteemed colleagues, including Julie Kay Bush and Merlyn G Flom. These collaborations have fostered a productive environment for innovation and have led to the successful development of new therapeutic solutions.
Conclusion
Preston Charles Conrad's contributions to the field of pharmaceuticals exemplify the impact of innovation in addressing critical health issues. His work continues to inspire advancements in medical research and development.